Top of this page
Skip navigation, go straight to the content Newsroom UCB U.S. News


  • Insurance Tips and Resources for Managing your Plan

    Posted by Katelyn Snider, U.S. Communications and Public Affairs1280x_960_UCB_B1_NavigatingInsurance_618963716_1280x550

    It’s that time of the year again. Open enrollment for insurance has closed, and it is time to start using your new 2018 plans. Sometimes, understanding your health coverage and planning for your healthcare needs can be challenging.

    Read more

  • Like
  • Case Study: The Right Patients at the Right Time

    Posted by Katelyn Snider, U.S. Communications and Public Affairs

    Following a recent review of Tussionex® (hydrocodone polistirex and chlorpheniramine polistirex) – a cough syrup containing hydrocodone and chlorpheniramine– we determined the benefit-risk balance for the use of Tussionex® to treat cough associated with cold or allergy in children was no longer favorable. Because of this, UCB proactively approached the U.S. Food and Drug Administration (FDA) to request that Tussionex® be limited to use in adults.

    Read more

  • Like